Advertisement

Index by author

November 01, 2004; Volume 32,Issue 11

  1. Koup, Jeffrey R.

    1. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
      J. Andrew Williams, Ruth Hyland, Barry C. Jones, Dennis A. Smith, Susan Hurst, Theunis C. Goosen, Vincent Peterkin, Jeffrey R. Koup and Simon E. Ball
      Drug Metabolism and Disposition November 2004, 32 (11) 1201-1208; DOI: https://doi.org/10.1124/dmd.104.000794

  2. Kretz, Olivier

    1. HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154
      Tappei Takada, H. Markus Weiss, Olivier Kretz, Gerhard Gross and Yuichi Sugiyama
      Drug Metabolism and Disposition November 2004, 32 (11) 1272-1278; DOI: https://doi.org/10.1124/dmd.104.000497

  3. Kunta, Jeevan R.

    1. DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752

  4. Lam, Justine L.

    1. HEPATIC MICROSOME STUDIES ARE INSUFFICIENT TO CHARACTERIZE IN VIVO HEPATIC METABOLIC CLEARANCE AND METABOLIC DRUG-DRUG INTERACTIONS: STUDIES OF DIGOXIN METABOLISM IN PRIMARY RAT HEPATOCYTES VERSUS MICROSOMES
      Justine L. Lam and Leslie Z. Benet
      Drug Metabolism and Disposition November 2004, 32 (11) 1311-1316; DOI: https://doi.org/10.1124/dmd.32.11.1311

  5. Lee, Sung-Hack

    1. DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752

  6. Lee, Yong-Hee

    1. DIFFERENTIATION OF GUT AND HEPATIC FIRST-PASS LOSS OF VERAPAMIL IN INTESTINAL AND VASCULAR ACCESS-PORTED (IVAP) RABBITS
      Jeevan R. Kunta, Sung-Hack Lee, Barbara A. Perry, Yong-Hee Lee and Patrick J. Sinko
      Drug Metabolism and Disposition November 2004, 32 (11) 1293-1298; DOI: https://doi.org/10.1124/dmd.104.000752

  7. Lennard, M. S.

    1. MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE
      A. Heydari, K. Rowland Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker and A. Rostami-Hodjegan
      Drug Metabolism and Disposition November 2004, 32 (11) 1213-1217; DOI: https://doi.org/10.1124/dmd.104.001180

  8. Li, Ning

    1. DOWN-REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDE 4 (Oatp4; Oatp1b2; Slc21a10) mRNA BY LIPOPOLYSACCHARIDE THROUGH THE TOLL-LIKE RECEPTOR 4 (TLR4)
      Ning Li, Supratim Choudhuri, Nathan J. Cherrington and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2004, 32 (11) 1265-1271; DOI: https://doi.org/10.1124/dmd.32.11.1265

  9. Liu, Jirong

    1. DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23
      Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester and Bingfang Yan
      Drug Metabolism and Disposition November 2004, 32 (11) 1317-1324; DOI: https://doi.org/10.1124/dmd.104.000786

  10. Lu, Ping

    1. CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT
      Rosa I. Sanchez, Regina W. Wang, Deborah J. Newton, Ray Bakhtiar, Ping Lu, Shuet-Hing Lee Chiu, David C. Evans and Su-Er W. Huskey
      Drug Metabolism and Disposition November 2004, 32 (11) 1287-1292; DOI: https://doi.org/10.1124/dmd.104.000216
« Previous (Pages : 2 3 4 5 6 7 8 9 10 11 ... 11) Next »
Back to top

In this issue

Advertisement